Souhaitez-vous accéder aux communiqués récents ?

MOUNTAIN VIEW, Calif., April 01, 2026 (GLOBE NEWSWIRE) -- RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a life-sciences company developing innovative targeted oncology therapies and...

IG Asia confirms a new Cu-Mo discovery at Uzhnaya Ploshchad within Pribrezhniy's 4.17Mt copper license — 6 of 10 holes hit, led by 1% CuEq over 77m.

New York, March 31, 2026 (GLOBE NEWSWIRE) -- Optimove, the creator of Positionless Marketing, announced new AI agents and AI-powered capabilities that improve and accelerate the entire content...

New York, March 31, 2026 (GLOBE NEWSWIRE) -- ELEHEAR is proud to have been named to Fast Company’s prestigious list of the World’s Most Innovative Companies of 2026. This year’s list shines a...

BOSTON, March 30, 2026 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced the dosing of the first...

Draupnir’s novel SORTAC platform expands reach of targeted protein degradation to extracellular proteins, demonstrating in vitro and in vivo efficacy against difficult-to-drug targetsStudy further...

Fabhalta lowered likelihood of progression to kidney failure by 43% in APPLAUSE-IgAN study140.7% of patients on Fabhalta demonstrated sustained reduction of protein in urine over two years1Fabhalta...

Results from the Phase 3 VELA clinical trials in adults with moderate-to-severe hidradenitis suppurativa (HS) show that clinical responses continue to improve to Week 40, with 62% of patients treated...

New York, March 27, 2026 (GLOBE NEWSWIRE) -- Optimove, the creator of Positionless Marketing, today announced the launch of AI Decisioning Studio, a single place where marketers can interact,...

BTCS Reports Full Year 2025 Financial Results